Sociedad Americana de Hirudoterapia

Leech C-Type Lectin

C-type lectin domain protein identified in Hirudo medicinalis salivary transcriptome — putative carbohydrate / glycoprotein binder.

Preclínico / mecanísticoLast updated: 2026-05-26 · Reviewed by ASH Editorial Board
Molecular weight of Leech C-Type Lectin compared with other characterized leech-derived compoundsHementerin80 kDaHementin80 kDaHementin-Like Protein (HLP-1)80 kDaLeech Collagenase70 kDaHaemadipsa yanyuanensis Progr…70 kDaLeech Apyrase67 kDaCalin65 kDaHyaluronidase60 kDaAntithrombin III binding prot…58 kDaCollagenolytic Fibrinolysin55 kDaLeech Thrombospondin-Like Pro…50 kDaLeech C-Type Lectin20 kDa
Molecular weight (kilodaltons) of Leech C-Type Lectin (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic
Page type
Compound profile
Evidence type
C-type lectin domain protein identified in Hirudo medicinalis salivary transcriptome — putative carbohydrate / glycoprotein binder.
Evidence level
Mechanistic discussion
Drug vs leech
Purified natural compound

Clinical translation limit

This C-type lectin is identified at the sequence level only. Hypothesized glycan-binding roles are NOT clinically validated. No FDA-approved derivative exists.

Molecular Profile

Category
Other
Evidence tier
Preclinical
Molecular weight
20,000 Da
Source species
Hirudo medicinalis
Discovered
2018
Leech C-Type Lectin molecular structure

Biological Targets

  • sialylated and galactose-containing glycoconjugates (predicted)

External Resources

    Related Other Compounds

    Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.